Literature DB >> 23795120

3-Benzyl-6-bromo-1H-imidazo[4,5-b]pyridin-2(3H)-one.

Youssef Kandri Rodi1, Amal Haoudi, Frédéric Capet, Ahmed Mazzah, El Mokhtar Essassi, Lahcen El Ammari.   

Abstract

The fused imidazole and pyridine rings in the title compound, C13H10BrN3O, are linked to a benzyl group. The fused ring system is essentially planar, the largest deviation from the mean plane being 0.006 (2) Å. The phenyl ring is not coplanar with the fused ring system, as indicated by the dihedral angle of 67.04 (12)°. In the crystal, mol-ecules are linked by pairs of N-H⋯O hydrogen bonds, forming inversion dimers.

Entities:  

Year:  2013        PMID: 23795120      PMCID: PMC3685101          DOI: 10.1107/S1600536813013780

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the biological activity of imidazo­pyridine derivatives, see: Chen & Dost (1992 ▶); Cappelli et al. (2006 ▶); Weier et al. (1994 ▶); Kulkarni & Newman (2007 ▶); Bavetsias et al. (2007 ▶, 2010 ▶).

Experimental

Crystal data

C13H10BrN3O M = 304.15 Triclinic, a = 4.2399 (2) Å b = 10.4463 (4) Å c = 14.5144 (6) Å α = 107.611 (2)° β = 90.628 (3)° γ = 99.784 (3)° V = 602.49 (4) Å3 Z = 2 Mo Kα radiation μ = 3.40 mm−1 T = 296 K 0.26 × 0.19 × 0.02 mm

Data collection

Bruker APEXII CCD diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2009 ▶) T min = 0.472, T max = 0.935 13819 measured reflections 2772 independent reflections 2169 reflections with I > 2σ(I) R int = 0.026

Refinement

R[F 2 > 2σ(F 2)] = 0.033 wR(F 2) = 0.085 S = 1.06 2772 reflections 163 parameters H-atom parameters constrained Δρmax = 0.56 e Å−3 Δρmin = −0.55 e Å−3 Data collection: APEX2 (Bruker, 2009 ▶); cell refinement: SAINT-Plus (Bruker, 2009 ▶); data reduction: SAINT-Plus; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012 ▶); software used to prepare material for publication: PLATON (Spek, 2009 ▶) and publCIF (Westrip, 2010 ▶). Click here for additional data file. Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S1600536813013780/fj2630sup1.cif Click here for additional data file. Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536813013780/fj2630Isup2.hkl Click here for additional data file. Supplementary material file. DOI: 10.1107/S1600536813013780/fj2630Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C13H10BrN3OZ = 2
Mr = 304.15F(000) = 304
Triclinic, P1Dx = 1.677 Mg m3
Hall symbol: -P 1Melting point: 358 K
a = 4.2399 (2) ÅMo Kα radiation, λ = 0.71073 Å
b = 10.4463 (4) ÅCell parameters from 2772 reflections
c = 14.5144 (6) Åθ = 1.5–27.5°
α = 107.611 (2)°µ = 3.40 mm1
β = 90.628 (3)°T = 296 K
γ = 99.784 (3)°Platelet, colourless
V = 602.49 (4) Å30.26 × 0.19 × 0.02 mm
Bruker APEXII CCD diffractometer2772 independent reflections
Radiation source: microfocus source2169 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.026
φ and ω scansθmax = 27.5°, θmin = 1.5°
Absorption correction: multi-scan (SADABS; Bruker, 2009)h = −5→5
Tmin = 0.472, Tmax = 0.935k = −13→13
13819 measured reflectionsl = −18→18
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.033Hydrogen site location: difference Fourier map
wR(F2) = 0.085H-atom parameters constrained
S = 1.06w = 1/[σ2(Fo2) + (0.0374P)2 + 0.3201P] where P = (Fo2 + 2Fc2)/3
2772 reflections(Δ/σ)max < 0.001
163 parametersΔρmax = 0.56 e Å3
0 restraintsΔρmin = −0.55 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against all reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on all data will be even larger.
xyzUiso*/Ueq
Br10.26054 (8)0.40434 (3)0.14153 (2)0.06526 (14)
C10.6829 (7)0.6528 (3)0.2362 (2)0.0522 (7)
H10.72690.60480.27790.063*
C20.4658 (7)0.5871 (3)0.15899 (19)0.0463 (6)
C30.3894 (6)0.6511 (3)0.09261 (18)0.0448 (6)
H30.24370.60730.03950.054*
C40.5450 (6)0.7837 (2)0.11128 (16)0.0373 (5)
C50.7610 (6)0.8423 (2)0.19198 (16)0.0379 (5)
C60.7491 (6)0.9986 (2)0.11485 (16)0.0387 (5)
C71.1131 (6)1.0750 (3)0.26618 (18)0.0433 (6)
H7A1.23621.13710.23630.052*
H7B1.26151.02890.28960.052*
C80.9545 (5)1.1565 (2)0.35104 (16)0.0381 (5)
C90.8773 (7)1.2797 (3)0.3530 (2)0.0503 (6)
H90.91881.31260.30080.060*
C100.7386 (8)1.3551 (3)0.4320 (2)0.0644 (8)
H100.68701.43850.43270.077*
C110.6766 (8)1.3071 (4)0.5096 (2)0.0647 (8)
H110.58651.35860.56320.078*
C120.7474 (8)1.1844 (4)0.5076 (2)0.0656 (8)
H120.70291.15130.55960.079*
C130.8849 (7)1.1088 (3)0.42872 (19)0.0536 (7)
H130.93131.02450.42780.064*
N10.8370 (6)0.7832 (2)0.25554 (15)0.0479 (5)
N20.8850 (5)0.9739 (2)0.19325 (14)0.0385 (4)
N30.5415 (5)0.8819 (2)0.06533 (14)0.0412 (5)
H140.42620.87120.01350.049*
O10.8058 (5)1.10622 (18)0.09525 (13)0.0507 (4)
U11U22U33U12U13U23
Br10.0925 (3)0.04191 (17)0.0673 (2)0.00734 (15)0.02819 (17)0.02745 (14)
C10.0752 (19)0.0483 (15)0.0458 (15)0.0241 (14)0.0182 (14)0.0259 (13)
C20.0615 (16)0.0352 (13)0.0453 (14)0.0094 (12)0.0203 (12)0.0159 (11)
C30.0572 (15)0.0369 (13)0.0378 (13)0.0036 (11)0.0109 (11)0.0103 (11)
C40.0468 (13)0.0346 (12)0.0323 (11)0.0084 (10)0.0083 (10)0.0121 (10)
C50.0437 (13)0.0369 (12)0.0352 (12)0.0119 (10)0.0100 (10)0.0113 (10)
C60.0460 (13)0.0358 (12)0.0345 (12)0.0060 (10)0.0040 (10)0.0119 (10)
C70.0357 (12)0.0496 (14)0.0428 (13)0.0047 (11)−0.0023 (10)0.0134 (12)
C80.0321 (12)0.0419 (13)0.0355 (12)−0.0009 (10)−0.0081 (9)0.0094 (10)
C90.0581 (16)0.0427 (14)0.0511 (15)0.0044 (12)0.0053 (12)0.0185 (12)
C100.074 (2)0.0440 (16)0.074 (2)0.0150 (15)0.0095 (17)0.0142 (15)
C110.069 (2)0.065 (2)0.0518 (17)0.0155 (16)0.0109 (14)0.0036 (15)
C120.080 (2)0.079 (2)0.0422 (15)0.0184 (18)0.0089 (14)0.0238 (15)
C130.0682 (18)0.0556 (17)0.0426 (14)0.0191 (14)0.0021 (13)0.0194 (13)
N10.0618 (13)0.0493 (13)0.0397 (11)0.0181 (11)0.0045 (10)0.0199 (10)
N20.0435 (11)0.0369 (10)0.0337 (10)0.0055 (9)−0.0001 (8)0.0099 (8)
N30.0544 (12)0.0349 (10)0.0324 (10)−0.0006 (9)−0.0056 (9)0.0125 (8)
O10.0670 (12)0.0366 (9)0.0466 (10)−0.0043 (8)−0.0091 (9)0.0177 (8)
Br1—C21.898 (3)C7—C81.507 (3)
C1—N11.350 (4)C7—H7A0.9700
C1—C21.368 (4)C7—H7B0.9700
C1—H10.9300C8—C91.372 (4)
C2—C31.392 (4)C8—C131.380 (4)
C3—C41.373 (3)C9—C101.381 (4)
C3—H30.9300C9—H90.9300
C4—N31.385 (3)C10—C111.375 (5)
C4—C51.392 (3)C10—H100.9300
C5—N11.320 (3)C11—C121.357 (5)
C5—N21.380 (3)C11—H110.9300
C6—O11.227 (3)C12—C131.378 (4)
C6—N31.367 (3)C12—H120.9300
C6—N21.381 (3)C13—H130.9300
C7—N21.458 (3)N3—H140.8600
N1—C1—C2123.9 (2)C9—C8—C7120.9 (2)
N1—C1—H1118.1C13—C8—C7120.5 (2)
C2—C1—H1118.1C8—C9—C10120.6 (3)
C1—C2—C3121.7 (2)C8—C9—H9119.7
C1—C2—Br1119.55 (19)C10—C9—H9119.7
C3—C2—Br1118.8 (2)C11—C10—C9120.0 (3)
C4—C3—C2115.1 (2)C11—C10—H10120.0
C4—C3—H3122.5C9—C10—H10120.0
C2—C3—H3122.5C12—C11—C10119.8 (3)
C3—C4—N3133.9 (2)C12—C11—H11120.1
C3—C4—C5119.2 (2)C10—C11—H11120.1
N3—C4—C5106.8 (2)C11—C12—C13120.2 (3)
N1—C5—N2125.9 (2)C11—C12—H12119.9
N1—C5—C4126.6 (2)C13—C12—H12119.9
N2—C5—C4107.5 (2)C12—C13—C8120.7 (3)
O1—C6—N3127.5 (2)C12—C13—H13119.6
O1—C6—N2125.6 (2)C8—C13—H13119.6
N3—C6—N2107.0 (2)C5—N1—C1113.6 (2)
N2—C7—C8113.10 (19)C5—N2—C6109.01 (19)
N2—C7—H7A109.0C5—N2—C7126.9 (2)
C8—C7—H7A109.0C6—N2—C7124.1 (2)
N2—C7—H7B109.0C6—N3—C4109.67 (19)
C8—C7—H7B109.0C6—N3—H14125.2
H7A—C7—H7B107.8C4—N3—H14125.2
C9—C8—C13118.6 (2)
N1—C1—C2—C30.8 (4)C7—C8—C13—C12178.3 (3)
N1—C1—C2—Br1−178.9 (2)N2—C5—N1—C1−179.1 (2)
C1—C2—C3—C4−0.6 (4)C4—C5—N1—C10.3 (4)
Br1—C2—C3—C4179.11 (17)C2—C1—N1—C5−0.6 (4)
C2—C3—C4—N3179.7 (2)N1—C5—N2—C6179.6 (2)
C2—C3—C4—C50.3 (3)C4—C5—N2—C60.2 (2)
C3—C4—C5—N1−0.1 (4)N1—C5—N2—C7−2.6 (4)
N3—C4—C5—N1−179.7 (2)C4—C5—N2—C7178.0 (2)
C3—C4—C5—N2179.3 (2)O1—C6—N2—C5179.4 (2)
N3—C4—C5—N2−0.3 (3)N3—C6—N2—C5−0.1 (3)
N2—C7—C8—C9−93.6 (3)O1—C6—N2—C71.5 (4)
N2—C7—C8—C1386.6 (3)N3—C6—N2—C7−177.9 (2)
C13—C8—C9—C101.2 (4)C8—C7—N2—C5−86.5 (3)
C7—C8—C9—C10−178.5 (3)C8—C7—N2—C691.0 (3)
C8—C9—C10—C110.0 (5)O1—C6—N3—C4−179.6 (2)
C9—C10—C11—C12−1.1 (5)N2—C6—N3—C4−0.1 (3)
C10—C11—C12—C130.9 (5)C3—C4—N3—C6−179.2 (3)
C11—C12—C13—C80.4 (5)C5—C4—N3—C60.3 (3)
C9—C8—C13—C12−1.4 (4)
D—H···AD—HH···AD···AD—H···A
N3—H14···O1i0.861.952.789 (3)166
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯A D—HH⋯A DA D—H⋯A
N3—H14⋯O1i 0.861.952.789 (3)166

Symmetry code: (i) .

  6 in total

1.  Discovery of heterobicyclic templates for novel metabotropic glutamate receptor subtype 5 antagonists.

Authors:  Santosh S Kulkarni; Amy Hauck Newman
Journal:  Bioorg Med Chem Lett       Date:  2007-03-24       Impact factor: 2.823

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Further studies on imidazo[4,5-b]pyridine AT1 angiotensin II receptor antagonists. Effects of the transformation of the 4-phenylquinoline backbone into 4-phenylisoquinolinone or 1-phenylindene scaffolds.

Authors:  Andrea Cappelli; Gal la Pericot Mohr; Germano Giuliani; Simone Galeazzi; Maurizio Anzini; Laura Mennuni; Flora Ferrari; Francesco Makovec; Eva M Kleinrath; Thierry Langer; Massimo Valoti; Gianluca Giorgi; Salvatore Vomero
Journal:  J Med Chem       Date:  2006-11-02       Impact factor: 7.446

4.  Imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases: lead optimization studies toward the identification of an orally bioavailable preclinical development candidate.

Authors:  Vassilios Bavetsias; Jonathan M Large; Chongbo Sun; Nathalie Bouloc; Magda Kosmopoulou; Mizio Matteucci; Nicola E Wilsher; Vanessa Martins; Jóhannes Reynisson; Butrus Atrash; Amir Faisal; Frederique Urban; Melanie Valenti; Alexis de Haven Brandon; Gary Box; Florence I Raynaud; Paul Workman; Suzanne A Eccles; Richard Bayliss; Julian Blagg; Spiros Linardopoulos; Edward McDonald
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

5.  Hit generation and exploration: imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases.

Authors:  Vassilios Bavetsias; Chongbo Sun; Nathalie Bouloc; Jóhannes Reynisson; Paul Workman; Spiros Linardopoulos; Edward McDonald
Journal:  Bioorg Med Chem Lett       Date:  2007-10-22       Impact factor: 2.823

6.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.